Molecular and clinicopathological characteristics of ROS1‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing

ROS1 gene rearrangements have been reported in diverse cancer types including non‐small‐cell lung cancer (NSCLC), and with a notably higher prevalence in lung adenocarcinoma. The tyrosine kinase inhibitors, crizotinib, lorlatinib, and entrectinib, have demonstrated favorable efficacy in treating ROS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Oncol
Main Authors: Cui, Meiying, Han, Yuchen, Li, Pan, Zhang, Jianying, Ou, Qiuxiang, Tong, Xiaoling, Zhao, Ruiying, Dong, Nan, Wu, Xue, Li, Wencai, Jiang, Guozhong
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7607175/
https://ncbi.nlm.nih.gov/pubmed/32871626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12789
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados